{"SPADE_UN_25719": {"Sequence Information": {"Peptide Name": "Cryptide AD7", "Sequence": "FLRWRLKFKSKVWCP", "Sequence Length": 15, "Biological Activity": ["Anti-Gram+", "Anti-Gram-", "Anticancer", "Antifungal", "Anti-Mammalian Cell", "Antibiofilm"], "Binding Target": "1. Lipid Bilayer", "Source": "", "Gene": "", "PDB ID": "", "UniProt Entry": [{"uniprotId": "A0A3R7PB52", "uniprotUrl": "http://www.uniprot.org/uniprot/A0A3R7PB52", "description": "The amino acid sequence of the current peptide coincides with the part of the UniProt entry that may represent a peptide precursor."}, {"uniprotId": "A0A3R7MWL6", "uniprotUrl": "http://www.uniprot.org/uniprot/A0A3R7MWL6", "description": "The amino acid sequence of the current peptide coincides with the part of the UniProt entry that may represent a peptide precursor."}], "Literature": [{"Title": "Novel cationic cryptides in Penaeus vannamei demonstrate antimicrobial and anti-cancer activities.", "Pubmed ID": "37673929", "Reference": "Sci Rep. 2023;13:14673", "Author": "Abd El-Aal AAA, Jayakumar FA, Lahiri C, Tan KO, Reginald K", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/37673929"}], "Mass": 1994.45, "PI": 11.11, "Net Charge": 5, "Hydrophobicity": -0.33, "Frequent Amino Acids": "KFL", "Absent Amino Acids": "ADEGHIMNOQTUY", "Basic Residues": 5, "Acidic Residues": 0, "Hydrophobic Residues": 6, "Polar Residues": 9, "Positive Residues": 5, "Negative Residues": 0, "SPADE ID": "SPADE_UN_25719", "Similar Sequences": [{"SPADE_ID": "SPADE_UN_18947", "Similarity": 1.0, "Sequence": "CPGGKRIVKRIKAFLRGPGGKRIVKRIKAFLR"}, {"SPADE_ID": "SPADE_UN_22747", "Similarity": 1.0, "Sequence": "KRIVQRIKDFLRAGPIKDFLR"}, {"SPADE_ID": "SPADE_UN_25719", "Similarity": 1.0, "Sequence": "FLRWRLKFKSKVWCP"}], "Hemolytic Activity": "Human embryonic kidney HEK293 cells:<10% Cell death=25 µM,Human erythrocytes:<10% Hemolysis=25 µM,Human erythrocytes:25% Hemolysis=100 µM", "Target Organism": "Bacillus subtilis ATCC 11774(MIC=0.39µM),Bacillus subtilis ATCC 11774(MBC=0.39µM),Staphylococcus aureus ATCC BAA-41(MIC=3.12µM),Staphylococcus aureus ATCC BAA-41(MBC=3.12µM),Salmonella enterica subsp. enterica serovar Typhimurium ATCC 14028(MIC=0.78µM),Salmonella enterica subsp. enterica serovar Typhimurium ATCC 14028(MBC=0.78µM),Pseudomonas aeruginosa ATCC 10145(MIC=6.25µM),Pseudomonas aeruginosa ATCC 10145(MBC=25µM),Vibrio parahaemolyticus ATCC 17802(MIC=3.12µM),Vibrio parahaemolyticus ATCC 17802(MBC=3.12µM),Candida albicans TIMM 1768(MIC=1.56µM),Candida albicans TIMM 1768(MFC=6.25µM),Human colon adenocarcinoma Caco-2(IC50=11.2±0.7µM),Human colon adenocarcinoma HCT 116(no activity data),Human lung carcinoma A549(IC50=8.5±0.6µM),Human cervical carcinoma HeLa(IC50=101.5±0.9µM),Human neuroblastoma SH-SY5Y(no activity data),Human rhabdomyosarcoma(IC50=97.8±0.2µM)"}}}